Neurogene (NGNE) Exchange Rate Effect (2015 - 2020)
Neurogene's (NGNE) quarterly Exchange Rate Effect came in at $14000.0 in Q2 2020, up 366.67% YoY from $3000.0 in Q3 2019, and up 227.27% on a QoQ basis from -$11000.0 in Q1 2020.
Powered by 
Analysis
Neurogene (NGNE) Exchange Rate Effect (2015 - 2020) Analysis & Trends
Neurogene (NGNE) has 6 years of Exchange Rate Effect data on file, last reported at $14000.0 in Q2 2020.
- Quarterly Exchange Rate Effect rose 366.67% year-over-year to $14000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2021 was $3000.0 (down 72.73% YoY) and the FY2019 annual result came in at $10000.0, up 120.83% from the prior year.
- Exchange Rate Effect grew to $14000.0 in Q2 2020, from -$11000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $41000.0 in Q1 2016 to a low of -$60000.0 in Q4 2016.
- A 5-year average of -$4055.6 and a median of $0.0 in 2019 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 366.67% in 2020, down 1000.0% in 2020.
- Tracing NGNE's Exchange Rate Effect over 5 years: stood at -$60000.0 in 2016, then jumped by 90.0% to -$6000.0 in 2017, then plunged by 333.33% to -$26000.0 in 2018, then jumped by 103.85% to $1000.0 in 2019, then surged by 1300.0% to $14000.0 in 2020.
- The last three Exchange Rate Effect figures came in at $14000.0 (Q2 2020), -$11000.0 (Q1 2020), and $1000.0 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Neurogene | 864.53 Mn | 864.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 14,000.00 |
| Mar 31, 2020 | -11,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Dec 31, 2018 | -26,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Mar 31, 2018 | 8,000.00 |
| Dec 31, 2017 | -6,000.00 |
| Sep 30, 2017 | 10,000.00 |
| Jun 30, 2017 | 4,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Dec 31, 2016 | -60,000.00 |
| Sep 30, 2016 | -24,000.00 |
| Jun 30, 2016 | -10,000.00 |
| Mar 31, 2016 | 41,000.00 |
| Dec 31, 2015 | -61,000.00 |
| Sep 30, 2015 | -67,000.00 |